X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (43162) 43162
Book Review (6497) 6497
Publication (5741) 5741
Book Chapter (355) 355
Newsletter (206) 206
Conference Proceeding (146) 146
Book / eBook (101) 101
Dissertation (54) 54
Magazine Article (26) 26
Newspaper Article (15) 15
Data Set (8) 8
Reference (7) 7
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (36081) 36081
animals (24425) 24425
humans (19921) 19921
male (12633) 12633
mice (10672) 10672
rats (9149) 9149
female (7176) 7176
biochemistry & molecular biology (5816) 5816
pharmacology & pharmacy (5708) 5708
cell biology (5487) 5487
neurosciences (5307) 5307
expression (5049) 5049
endocrinology & metabolism (4729) 4729
signal transduction (4691) 4691
cells, cultured (4598) 4598
activation (4239) 4239
proteins (4128) 4128
inflammation (4065) 4065
rodents (3844) 3844
gene expression (3795) 3795
phosphorylation (3681) 3681
article (3496) 3496
immunology (3436) 3436
research (3436) 3436
rats, sprague-dawley (3426) 3426
physiology (3425) 3425
mice, inbred c57bl (3417) 3417
analysis (3320) 3320
physiological aspects (3258) 3258
diabetes (3156) 3156
cell line (2958) 2958
dose-response relationship, drug (2904) 2904
receptor (2798) 2798
apoptosis (2781) 2781
cells (2781) 2781
multidisciplinary sciences (2543) 2543
adult (2506) 2506
middle aged (2482) 2482
receptors (2480) 2480
gene-expression (2440) 2440
research article (2432) 2432
signal transduction - drug effects (2408) 2408
insulin (2404) 2404
medicine (2368) 2368
mice, knockout (2311) 2311
health aspects (2274) 2274
cytokines (2241) 2241
disease models, animal (2221) 2221
abridged index medicus (2190) 2190
glucose (2184) 2184
kinases (2178) 2178
rats, wistar (2165) 2165
oncology (1980) 1980
brain (1972) 1972
mitogen-activated protein kinase 1 - metabolism (1957) 1957
cancer (1908) 1908
cell line, tumor (1874) 1874
rna, messenger - metabolism (1870) 1870
glucagon-like peptide-1 (1852) 1852
oxidative stress (1833) 1833
ligands (1831) 1831
metabolism (1822) 1822
type 2 diabetes (1820) 1820
science (1815) 1815
obesity (1802) 1802
in-vivo (1790) 1790
time factors (1778) 1778
inhibition (1759) 1759
medicine, research & experimental (1752) 1752
peptides (1718) 1718
care and treatment (1717) 1717
neurons (1614) 1614
genetic aspects (1578) 1578
glucagon (1578) 1578
calcium - metabolism (1570) 1570
diabetes mellitus (1553) 1553
diabetes mellitus, type 2 - drug therapy (1551) 1551
aged (1548) 1548
biology (1542) 1542
in-vitro (1542) 1542
rat (1505) 1505
protein binding (1471) 1471
blotting, western (1467) 1467
immunohistochemistry (1449) 1449
enzyme inhibitors - pharmacology (1434) 1434
gene expression regulation (1423) 1423
medicine & public health (1408) 1408
mitogen-activated protein kinase 3 - metabolism (1383) 1383
in vitro techniques (1373) 1373
macrophages (1347) 1347
type 1 diabetes (1329) 1329
biochemistry (1324) 1324
signal transduction - physiology (1323) 1323
up-regulation (1310) 1310
glucagon-like peptide 1 (1307) 1307
transfection (1299) 1299
risk factors (1294) 1294
lipids (1278) 1278
pharmacology (1276) 1276
gene expression regulation - drug effects (1262) 1262
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (63) 63
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Online Resources - Online (6) 6
UTL at Downsview - May be requested (5) 5
UofT at Scarborough - Stacks (5) 5
St. Michael's Hospital - Stacks (3) 3
Toronto East General Hospital - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Providence Healthcare - Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Scarborough Hospital - General (2) 2
Baycrest Hospital - Stacks (1) 1
Chemistry (A D Allen) - Reference (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Periodical Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
OISE - Stacks (1) 1
Physics - Storage (1) 1
Providence Healthcare - Withdrawn (1) 1
Robarts - Reference (1) 1
Robarts - Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (43497) 43497
German (67) 67
Japanese (64) 64
Chinese (46) 46
Spanish (26) 26
French (21) 21
Russian (15) 15
Korean (14) 14
Portuguese (8) 8
Polish (7) 7
Italian (6) 6
Czech (5) 5
Hungarian (4) 4
Swedish (2) 2
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 10/2014, Volume 124, Issue 10, pp. 4473 - 4488
Journal Article
JAMA, ISSN 0098-7484, 12/2018, Volume 320, Issue 24, pp. 2521 - 2521
Treatment with LY3298176, a novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 (GLP-1) receptor agonist, resulted in better... 
MEDICINE, GENERAL & INTERNAL | Side effects | Polypeptides | Glucagon | Medical treatment | Diabetes mellitus | GIP protein | Diabetes | Glucose | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1
Journal Article
Journal Article
Glia, ISSN 0894-1491, 02/2019, Volume 67, Issue 2, pp. 345 - 359
Prematurity and fetal growth restriction (FGR) are frequent conditions associated with adverse neurocognitive outcomes. We have previously identified early... 
myelination | oxytocin | perinatal stress | microglia | neuroprotection | CARBETOCIN | INJURY | NEUROSCIENCES | SOCIAL-BEHAVIOR | INFLAMMATION | INFANTS | INTRAUTERINE GROWTH RESTRICTION | FETAL | CEREBRAL-PALSY | PRETERM | FOR-GESTATIONAL-AGE | Peptide Fragments | Brain Injuries - drug therapy | Green Fluorescent Proteins - genetics | RNA, Messenger - metabolism | Diet, Protein-Restricted - adverse effects | Female | Oxytocics - therapeutic use | Disease Models, Animal | Animals, Newborn | Green Fluorescent Proteins - metabolism | Lipopolysaccharides - toxicity | Microglia - drug effects | Animals, Genetically Modified | Brain Injuries - chemically induced | Cells, Cultured | Computational Biology | Zebrafish | Interleukin-1beta | Prenatal Exposure Delayed Effects - physiopathology | Oxytocin - analogs & derivatives | Pregnancy | Receptors, Oxytocin - metabolism | Animals | Brain - pathology | Brain Injuries - pathology | Oxytocin - therapeutic use | Prenatal Exposure Delayed Effects - chemically induced | Neuroprotection | Brain | Deregulation | Interleukin | Cognition | Damage prevention | Neuromodulation | Proteins | Head injuries | Transcription activation | Interleukin 1 | Supplementation | Low protein diet | Nutrient deficiency | Oxytocin | Fetuses | Dietary supplements | Inflammation | Substantia alba | Microglia | Myelination | Neural networks | Brain damage | Brain injury | Index Medicus
Journal Article
Diabetes, ISSN 0012-1797, 04/2010, Volume 59, Issue 4, pp. 1030 - 1037
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 2019, Volume 321, Issue 15, pp. E1 - E2
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 10/2014, Volume 289, Issue 44, pp. 30538 - 30555
Previous data demonstrate that bexarotene (Bex), retinoid X receptor (RXR) agonist, reduces soluble and insoluble amyloid-beta (A beta) in Alzheimer disease... 
BEXAROTENE THERAPY | ABCA1 | ALZHEIMERS-DISEASE | DEPOSITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | LIVER | A-BETA | TRANSGENIC MOUSE MODEL | MILD COGNITIVE IMPAIRMENT | BRAIN | APOLIPOPROTEIN-E | Disks Large Homolog 4 Protein | Liver - pathology | Nicotinic Acids - pharmacokinetics | Humans | Male | Tetrahydronaphthalenes - adverse effects | ATP Binding Cassette Transporter 1 - metabolism | Liver - drug effects | Tetrahydronaphthalenes - administration & dosage | Amyloid beta-Peptides - metabolism | Lipoproteins - metabolism | ATP-Binding Cassette Transporters - metabolism | Membrane Proteins - metabolism | Nicotinic Acids - administration & dosage | Drug Evaluation, Preclinical | Nicotinic Acids - adverse effects | Retinoid X Receptors - metabolism | ATP Binding Cassette Transporter, Subfamily G, Member 1 | Bexarotene | Peptide Fragments - metabolism | Administration, Oral | Mice, Inbred C57BL | Solubility | Alzheimer Disease - drug therapy | Tetrahydronaphthalenes - pharmacokinetics | Genotype | Mice, Transgenic | Organ Size - drug effects | Animals | Retinoid X Receptors - agonists | Apolipoproteins E - genetics | Guanylate Kinases - metabolism | Index Medicus | Molecular Bases of Disease | Oligomeric Aβ | Alzheimer Disease | Drug Delivery | Aβ Complex | Apolipoprotein E (ApoE) | Amyloid-β (AB) | RXR Agonists | Hepatomegaly | ABCG1 Lipid Transporters | Drug Action | ApoE
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 08/2010, Volume 21, Issue 8, pp. 1290 - 1298
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0132744 - e0132744
Recently, a number of studies have demonstrated the potential beneficial role for novel antidiabetic GLP-1 receptor agonists (GLP-1RAs) in the skeleton... 
PROGENITORS | IN-VITRO | MARROW | RESORPTION | OSTEOBLAST FORMATION | EXENDIN-4 | MULTIDISCIPLINARY SCIENCES | MICE | DIFFERENTIATION | GLP-1 RECEPTOR | MESENCHYMAL STEM-CELLS | Mesenchymal Stromal Cells - drug effects | Bone and Bones - physiology | Osteoporosis - prevention & control | Ovariectomy | Rats, Wistar | Adipogenesis - drug effects | Humans | Osteoblasts - drug effects | Osteogenesis - drug effects | Cells, Cultured | Diabetes Mellitus - metabolism | Rats | Male | PPAR gamma - metabolism | Bone and Bones - drug effects | Bone Density - drug effects | Mesenchymal Stromal Cells - cytology | Anabolic Agents - pharmacology | Animals | Osteoporosis - pathology | Liraglutide - pharmacology | Female | Osteoporosis - physiopathology | Glucagon-Like Peptide-1 Receptor - agonists | Osteoporosis | Glucagon | Physiological aspects | Bones | Hypoglycemic agents | Diabetes | Density | Alkaline phosphatase | Peptides | Menopause | Hormones | Adipocytes | Bone surgery | Biomedical materials | Computed tomography | Rodents | Surgery | Bone marrow | Biocompatibility | Skeleton | Glucagon-like peptide 1 | Cbfa-1 protein | Vertebrae | Diabetes mellitus | Gene expression | Metabolism | Insulin | Medicine | Osteoblastogenesis | Bone mass | Stromal cells | Collagen | Stem cells | Bone mineral density | Laboratory animals | Endocrinology | Metabolic disorders | Index Medicus
Journal Article